Comparative effectiveness and acceptability of the FDA-licensed proton pump inhibitors for erosive esophagitis: A PRISMA-compliant network meta-analysis

BACKGROUND: This study compared the effectiveness and acceptability of all Food and Drug Administration (FDA)-recommended dose proton pump inhibitors (PPIs) in erosive esophagitis (EE): Dexlansoprazole 60 mg, Esomeprazole 40 mg, Esomeprazole 20 mg, Pantoprazole 40 mg, Lansoprazole 30 mg, Rabeprazole...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Mei-Juan, Li, Qing, Sun, Min, Liu, Li-Qin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2017
Materias:
4500
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5626283/
https://www.ncbi.nlm.nih.gov/pubmed/28953640
http://dx.doi.org/10.1097/MD.0000000000008120

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5626283/
https://www.ncbi.nlm.nih.gov/pubmed/28953640
http://dx.doi.org/10.1097/MD.0000000000008120

Ejemplares similares